Trump confirms review of US position on Falkland Islands amid defense spending pressure

Trump confirms review of Falklands policy

President Donald Trump said Monday that the United States is reviewing its position on the Falkland Islands, responding to a question in the Oval Office about the sovereignty of the South Atlantic archipelago. "I always review every position. That's just one of many," Trump told reporters, as quoted by multiple news outlets. He did not signal whether the review would lead to any change in Washington's stance, which has generally avoided taking sides on sovereignty since the 1982 conflict between Britain and Argentina over the islands.

Asked about the spending commitments of new British Prime Minister Andy Burnham, Trump replied, "The UK's got some problems but they'll get solved." The remarks came amid reports that the Pentagon had been drawing up measures to incentivize NATO allies to meet defense spending pledges, with the Falklands question potentially used as leverage.

The Daily Telegraph reported last week that a Pentagon review aimed at getting US allies to hit a 5-percent defense spending target could give Britain "special attention" by threatening to oppose British sovereignty outright. That report was cited by several outlets, including Bangkok Post and Hindustan Times. The Straits Times noted that a potential shift was among options considered by the Pentagon earlier this year to pressure NATO allies that Washington believed failed to support US military operations in the war with Iran. The Guardian reported that a leaked Pentagon email suggested reviewing Britain's claim in response to its lack of support for Trump's decision to go to war with Iran.

Officially, the United States maintains a neutral position on who holds rightful sovereignty over the Falkland Islands, which it has recognized as under British administration since the 1980s. The US State Department told AFP in April, when reports of a possible review first emerged, that "our position on The Islands remains one of neutrality."

That neutrality dates back to the 1982 Falklands War, when then-president Ronald Reagan initially took a neutral stance but, after peace talks broke down, Washington gave Britain military and intelligence support. The conflict, which began with an Argentine invasion of the British overseas territory, left 649 Argentines, 255 Britons, and three islanders dead.

Background and context

The Falkland Islands, known as "Las Malvinas" in Argentina, have been a point of tension between Britain and Argentina for decades. In a 2013 poll, 1,513 out of 1,517 Falklands residents voted to remain part of the UK, as reported by The Guardian. Argentina, led by Trump ally Javier Milei, continues to claim sovereignty over the islands, according to The Straits Times.

Tensions have flared again recently. Earlier this year, after Argentina beat England 2-1 in the World Cup semi-final, Argentine players held up a banner reading "The Falklands are Argentine" (or "Las Malvinas son Argentinas"), and FIFA later fined the Argentinian Football Association — with reports of the fine varying, with Bangkok Post and Hindustan Times reporting $321,000 and The Guardian reporting $235,000.

The Guardian reported that Trump's comments were the clearest sign yet that his administration was prepared to use the Falklands dispute as leverage to pressure the government of Prime Minister Andy Burnham to raise defense spending and contributions to NATO. This followed reports that John Healey, the UK chancellor, was preparing to drop Britain's prior commitment to devote 3% of GDP to defense spending by 2030 when he delivers his first budget on 28 October.

At a NATO summit in The Hague last year, allies committed to spending 5% of GDP on defense and security-related expenditures by 2035, as noted by The Guardian. Trump has made pressuring allies to boost defense budgets a priority, accusing other countries of "freeloading."

Trump's comments on the Falklands came as he also made unrelated remarks about the US pharmaceutical market, stating that 26 companies represent 90% of the pharma market — a claim reported by trade.

The review is ongoing, and no further details regarding its scope, timeline, or outcome have been provided, according to trade.